Introduction Cervical cancer remains one of the leading causes of cancer-related deaths among women globally, despite being almost ...

Since its first approval in 2022, Gilead Sciences’ lenacapavir—a twice-yearly injectable—has come to be a potential game ...

Pfizer’s stake in ViiV Healthcare will be taken over by Shiongi, another minority shareholder in the HIV medicines company.

New pilot partnership links at-home HIV screening with clinical prevention and treatment services across Ontario. TORONTO, ON ...

Discover how UCSF is leading the charge in Long COVID research, uncovering key findings that advance our understanding of the condition. UCSF researchers have adapted innovative tools and ...

Decoding the complex communication system of the deadliest brain cancer has revealed that an already approved HIV drug could ...

Researchers found that lithium can suppress HIV reactivation in lab-grown human cells through an unexpected, ...

BBC The life of Uganda’s veteran opposition figure Kizza Besigye is in danger, his wife has said after visiting him in prison ...

Q Care Plus, a telehealth provider known for its leadership in providing HIV prevention and treatment and sexual wellness care, today announced the addition of treatment for erectile dysfunction (ED), ...

Over 16,000 individuals living with HIV in Florida might lose access to their essential medications starting March 1 due to a ...

Rahul Purwar, Founder & Chairman of ImmunoACT outlined expansion plans beyond Africa, targeting Eastern Europe, other European countries and eventually the United States.

Fungal infections are becoming deadlier as drug resistance spreads and treatment options stall. Researchers at McMaster University discovered that a molecule called butyrolactol A can dramatically ...